private:quantapore
|
1722209
|
May 31st, 2019 12:00AM
|
Quantapore Inc.
|
321
|
28.00
|
Open
|
Biotechnology
|
May 31st, 2019 08:25AM
|
May 31st, 2019 08:25AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
Open
|
|
Open
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 17th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases. Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost. The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 16th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 15th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 14th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 13th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 12th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 11th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 10th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|
private:quantapore
|
1722209
|
Feb 9th, 2018 12:00AM
|
Quantapore Inc.
|
176
|
17.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Quantapore’s novel, high throughput, massively parallel sequencer will allow rapid, affordable and sensitive sequencing of entire genomes. This desktop system will address the need for efficient sequencing. Revenues will be garnered by seeding units into customer facilities, and then by the sale of consumable cartridges; providing rapid growth as the installed base and customer utilization increases.
Quantapore’s novel, proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.
The global market for genetics/genomics is estimated at $5.8 billion, while the DNA sequencing segment is estimated at ~$2.7 billion. The sequencing market will approximately double by 2015 with equipment and consumable sales representing around 2/3 of the total market. However, the un-tapped potential of this market is currently estimated at about $30 billion, leaving a large unmet demand for sequencing.
|
|
|
|
|
|
|
|
|
|
Quantapore
|
|
Health Care Equipment & Services
|